BSS is a Ophthalmic Solution in the Human Prescription Drug category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is Sodium Chloride; Potassium Chloride; Calcium Chloride; Magnesium Chloride; Sodium Acetate; Sodium Citrate.
| Product ID | 0065-1795_4618b4eb-bfc6-b49a-034f-cf332b1461c4 |
| NDC | 0065-1795 |
| Product Type | Human Prescription Drug |
| Proprietary Name | BSS |
| Generic Name | Balanced Salt Solution |
| Dosage Form | Solution |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 1969-03-28 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020742 |
| Labeler Name | Alcon Laboratories, Inc. |
| Substance Name | SODIUM CHLORIDE; POTASSIUM CHLORIDE; CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; SODIUM ACETATE; SODIUM CITRATE |
| Active Ingredient Strength | 6 mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL |
| Pharm Classes | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 1969-03-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020742 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1969-03-28 |
| Ingredient | Strength |
|---|---|
| SODIUM CHLORIDE | 6.4 mg/mL |
| SPL SET ID: | 28488c7b-cf6a-4a03-916f-cc66b3afdc57 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0065-0795 | BSS | balanced salt solution |
| 0065-1795 | BSS | balanced salt solution |